Month: <span>April 2018</span>

Home / 2018 / April
Post

Topical solution may be less toxic option for patients with noncancerous skin growth

George Washington University researchers published a study on an FDA-approved topical solution for the treatment of seborrheic keratosis GEORGE WASHINGTON UNIVERSITY WASHINGTON (March 29, 2018) — Seborrheic keratosis is the most common noncancerous skin growth in adults seen by doctors in everyday practice. While it can look like skin cancer, seborrheic keratosis is not thought...

Post

Tumor suppressor protein targets liver cancer

Salk Institute scientists, together with researchers from Switzerland’s University of Basel and University Hospital Basel, discovered a protein called LHPP that acts as a molecular switch to turn off the uncontrolled growth of cells in liver cancer. The tumor suppressor, which could be useful as a biomarker to help diagnose and monitor treatment for liver...

Post

Anti-aging protein alpha Klotho’s molecular structure revealed

Researchers from UT Southwestern’s Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine’s Division of Nephrology recently published work in Nature that reveals the molecular structure of the so-called “anti-aging” protein alpha Klotho (a-Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes. The investigation was performed...

Post

Colon signaling pathway key to inflammatory bowel disease

Tokyo Medical and Dental University (TMDU) -led research reveals role of signaling pathway in development of dysregulated immune cells capable of inducing inflammation in the colon  Tokyo -The intestine encounters more foreign substances, and potential toxins, than other parts of the body, so it is not surprising that a healthy gut is maintained by the...

Post

Researchers find ways to impede progress of neuro-degenerative diseases

Kazan University’s partner in this research is the Arbuzov Institute of Organic and Physical Chemistry. The joint team proved that water-soluble polyol-methanofullerenes C60[C9H10O4(OH)4]6 and C60[C13H18O4(OH)4]6 can decrease mitochondrial transmembrane potential. This makes them promising in the creation of targeted mitochondrial medications and composites based on them. As the paper posits, there is currently no doubt...

Post

Scientists develop sugar-coated nano sheets to selectively target pathogens

Researchers have developed a process for creating ultrathin, self-assembling sheets of synthetic materials that can function like designer flypaper in selectively binding with viruses, bacteria, and other pathogens. In this way the new platform, developed by a team led by scientists at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab), could potentially...

Post

Scientists find mini gastrointestinal tract growing inside tumor

Lung tumors have been found to morph into developmentally related neighboring organs, namely the gut.TATA LAB/DUKE UNIVERSITY Embedded in a lung cancer tumor, scientists have found a gastrointestinal tract in miniature. Duke University researchers have observed rudimentary, but functional, stomachs, small intestines, and duodenums growing inside cancerous lungs — illustrating how varied and plastic these...

Post

Newly discovered metabolic mechanism could be an off-switch for inflammation

Researchers at Trinity College Dublin have uncovered a new metabolic process involved in the immune system’s inflammatory processes. The discovery suggests manipulating this mechanism could essentially “switch off” inflammation, which the researchers hope could lead to the development of entirely new anti-inflammatory drugs to treat a host of auto-immune disorders. When the body is working...

Post

Soft Electronics for Long Term Neural Monitoring and Recording

Scientists at ETH Zurich in Switzerland, Linköping University in Sweden, and Columbia and NYU in New York City, have developed a highly flexible soft electronic neural interface probe that can be stretched to twice its original length. The device is suitable for long-term neural recording, and could help clinicians to diagnose and monitor neurological conditions...

Post

Dexcom G6 Continuous Glucometer Doesn’t Require Finger Pricks

Dexcom landed FDA clearance under the de novo classification process for its Dexcom G6 continuous glucose monitor, which can be used as a standalone monitor or as a part of an automated insulin delivery system. The neatest feature of the Dexcom G6 is that the sensor doesn’t require calibration and so pricking the finger can be a thing...